SCHEMBL3031915

SCHEMBL3031915

CC(=O)C(CC=O)(c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 5/20 0.45
DRD3 P35462 4/20 0.45
DRD4 P21917 3/20 0.45
DRD2 P14416 2/20 0.45
ALDH1A1 P00352 1/20 0.42
TSHR P16473 1/20 0.42
GRIN2D O15399 2/20 0.41
GRIN1 Q05586 2/20 0.41
GRIN2A Q12879 2/20 0.41
GRIN2B Q13224 2/20 0.41
GRIN2C Q14957 2/20 0.41
KCNH2 Q12809 2/20 0.41
CACNA1F O60840 1/20 0.41
ABCB1 P08183 1/20 0.41
CYP2B6 P20813 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
CACNA1D Q01668 1/20 0.41
CACNA1S Q13698 1/20 0.41
CACNA1C Q13936 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989858 0.84 ALDH1A1 (0.48) OPRM1DRD3DRD4DRD2ALDH1A1
SCHEMBL24683657 0.84 OPRM1 (0.61) OPRM1DRD3DRD4DRD2TSHR
SCHEMBL24684840 0.84 OPRM1 (0.41) OPRM1DRD3DRD4DRD2ALDH1A1
SCHEMBL8661322 0.81 OPRM1 (0.58) OPRM1DRD3DRD4DRD2ALDH1A1
SCHEMBL392176 0.80 KCNN4 (0.55) OPRM1DRD3DRD4DRD2ALDH1A1
SCHEMBL4640323 0.78 CHRM2 (0.48) OPRM1DRD3DRD2ALDH1A1TSHR
SCHEMBL24683697 0.74 OPRM1 (0.54) OPRM1DRD3DRD4DRD2TSHR
SCHEMBL10769662 0.73 ALDH1A1 (0.46) ALDH1A1TSHRKMT2ACHRM2CHRM1
SCHEMBL27517247 0.73 KCNN4 (0.50) OPRM1ALDH1A1TSHROPRD1CYP2C19
SCHEMBL11648782 0.72 CYP2C19 (0.46) ALDH1A1TSHRCYP2C19HIF1AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2142657-A1 USE OF THE PIGD PROTEIN FOR CATALYZING 1,4-ADDITIONS OF 2-OXOALKANOATES TO ALPHA, BETA-UNSATURATED KETONES Albert-Ludwigs-Universität Freiburg (DE) 2010-01-13 EP disclosed
EP-2059238-A2 THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS Myriad Genetics, Inc. (US) 2009-05-20 EP disclosed
WO-2008138450-A1 USE OF THE PIGD PROTEIN FOR CATALYZING 1,4-ADDITIONS OF 2-OXOALKANOATES TO ALPHA, BETA-UNSATURATED KETONES ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) 2008-11-20 WO disclosed
WO-2008031034-A2 THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS MYRIAD GENETICS, INC. (US) 2008-03-13 WO disclosed